Trials / Sponsors / Leading BioSciences, Inc
Leading BioSciences, Inc
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia COVID-19, Coronavirus Disease 2019, Covid19 | Phase 2 | 2021-10-31 |
| Terminated | Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 Septic Shock | Phase 2 | 2015-04-01 |